Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposu